Literature DB >> 21304473

Diagnostic and therapeutic strategies for small abdominal aortic aneurysms.

Ahmed Klink1, Fabien Hyafil, James Rudd, Peter Faries, Valentin Fuster, Ziad Mallat, Olivier Meilhac, Willem J M Mulder, Jean-Baptiste Michel, Francesco Ramirez, Gert Storm, Robert Thompson, Irene C Turnbull, Jesus Egido, Jose L Martín-Ventura, Carlos Zaragoza, Didier Letourneur, Zahi A Fayad.   

Abstract

Abdominal aortic aneurysms (AAA) affect 5% of the population in developed countries and are characterized by progressive aortic dilatation with an unpredictable time course. This condition is more common in men than in women, and in smokers than in nonsmokers. If left untreated, AAA can result in aortic rupture and death. Pathologically, aortic extracellular matrix degradation, inflammation, and neovascularization are hallmarks of AAA. Diagnosis of AAA and subsequent surveillance utilize established aortic imaging methods, such as ultrasound, CT, and MRI. More-speculative diagnostic approaches include molecular and cellular imaging methods that interrogate the underlying pathological processes at work within the aneurysm. In this Review, we explore the current diagnostic and therapeutic strategies for the management of AAA. We also describe the diagnostic potential of new imaging techniques and therapeutic potential of new treatments for the management of small AAA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304473     DOI: 10.1038/nrcardio.2011.1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  118 in total

1.  Feasibility of using dynamic contrast-enhanced magnetic resonance angiography as the sole imaging modality prior to endovascular repair of abdominal aortic aneurysms.

Authors:  C N Ludman; S W Yusuf; S C Whitaker; R H Gregson; S Walker; B R Hopkinson
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-05       Impact factor: 7.069

Review 2.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

Review 3.  Multimodality nanotracers for cardiovascular applications.

Authors:  Willem J M Mulder; David P Cormode; Sjoerd Hak; Mark E Lobatto; Stephane Silvera; Zahi A Fayad
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08

4.  Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm.

Authors:  W W Reed; J W Hallett; M A Damiano; D J Ballard
Journal:  Arch Intern Med       Date:  1997-10-13

5.  Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.

Authors:  Daniel G Hackam; Deva Thiruchelvam; Donald A Redelmeier
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

6.  Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study.

Authors:  R A Scott; N M Wilson; H A Ashton; D N Kay
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

7.  High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress.

Authors:  X Y Xu; A Borghi; A Nchimi; J Leung; P Gomez; Z Cheng; J O Defraigne; N Sakalihasan
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-11-18       Impact factor: 7.069

8.  Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.

Authors:  B Timothy Baxter; William H Pearce; Eugene A Waltke; Fred N Littooy; John W Hallett; K Craig Kent; Gilbert R Upchurch; Elliot L Chaikof; Joseph L Mills; Beverly Fleckten; G Matt Longo; Jason K Lee; Robert W Thompson
Journal:  J Vasc Surg       Date:  2002-07       Impact factor: 4.268

9.  Search for serum biomarkers associated with abdominal aortic aneurysm growth--a pilot study.

Authors:  M Vega de Céniga; M Esteban; J M Quintana; A Barba; L Estallo; N de la Fuente; B Viviens; J L Martin-Ventura
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-12-25       Impact factor: 7.069

10.  TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.

Authors:  Yu Wang; Hafid Ait-Oufella; Olivier Herbin; Philippe Bonnin; Bhama Ramkhelawon; Soraya Taleb; Jin Huang; Georges Offenstadt; Christophe Combadière; Laurent Rénia; Jason L Johnson; Pierre-Louis Tharaux; Alain Tedgui; Ziad Mallat
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

View more
  25 in total

Review 1.  Molecular imaging of aortic aneurysms.

Authors:  Denis B Buxton
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-01       Impact factor: 7.792

2.  Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression.

Authors:  Kory J Blose; Terri L Ennis; Batool Arif; Justin S Weinbaum; John A Curci; David A Vorp
Journal:  Regen Med       Date:  2014       Impact factor: 3.806

3.  Patient-Specific Prediction of Abdominal Aortic Aneurysm Expansion Using Bayesian Calibration.

Authors:  Liangliang Zhang; Zhenxiang Jiang; Jongeun Choi; Chae Young Lim; Tapabrata Maiti; Seungik Baek
Journal:  IEEE J Biomed Health Inform       Date:  2019-01-30       Impact factor: 5.772

4.  Can FDG-PET imaging play a role in guiding indications to endovascular treatments in patients presenting acute aortic syndromes?

Authors:  Michael Soussan; Fabien Hyafil
Journal:  J Nucl Cardiol       Date:  2017-10-16       Impact factor: 5.952

5.  In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging.

Authors:  Ahmed Klink; Joeri Heynens; Beatriz Herranz; Mark E Lobatto; Teresa Arias; Honorius M H F Sanders; Gustav J Strijkers; Maarten Merkx; Klaas Nicolay; Valentin Fuster; Alain Tedgui; Ziad Mallat; Willem J M Mulder; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

6.  Roadmap on nanomedicine.

Authors:  Paolo Decuzzi; Dan Peer; Daniele Di Mascolo; Anna Lisa Palange; Purnima Naresh Manghnani; S Moein Moghimi; Z Shadi Farhangrazi; Kenneth A Howard; Daniel Rosenblum; Tingxizi Liang; Zhaowei Chen; Zejun Wang; Jun-Jie Zhu; Zhen Gu; Netanel Korin; Didier Letourneur; Cédric Chauvierre; Roy van der Meel; Fabian Kiessling; Twan Lammers
Journal:  Nanotechnology       Date:  2021-01-01       Impact factor: 3.874

7.  Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms.

Authors:  Chris A Bashur; Raj R Rao; Anand Ramamurthi
Journal:  Stem Cells Transl Med       Date:  2013-05-15       Impact factor: 6.940

8.  PPAR-γ agonist attenuates inflammation in aortic aneurysm patients.

Authors:  Tatsuo Motoki; Hirotsugu Kurobe; Yoichiro Hirata; Taisuke Nakayama; Hajime Kinoshita; Kevin A Rocco; Hitoshi Sogabe; Takaki Hori; Masataka Sata; Tetsuya Kitagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-27

9.  Interaction between widening of diameter of abdominal aorta and cardiovascular risk factors and atherosclerosis burden.

Authors:  Frédéric Glauser; Lucia Mazzolai; Roger Darioli; Michèle Depairon
Journal:  Intern Emerg Med       Date:  2013-04-09       Impact factor: 3.397

10.  Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation.

Authors:  Chetan P Hans; Sara N Koenig; Nianyuan Huang; Jeeyun Cheng; Susana Beceiro; Anuradha Guggilam; Helena Kuivaniemi; Santiago Partida-Sánchez; Vidu Garg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-18       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.